Canrib Olaparib 150mg Tablet

Description

Introduction Of Canrib Tablet

CANRIB 150mg (Olaparib) is a medication that belongs to a class of drugs called poly (ADP-ribose) polymerase (PARP) inhibitors. It is primarily used in the treatment of certain types of cancer. CANRIB 150mg (Olaparib) is available in different strengths, including the 150mg formulation.

Uses Of Canrib 150mg Tablet

CANRIB 150mg (Olaparib 150mg) is primarily used for the treatment of advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is specifically indicated for patients who have a mutation in either the BRCA1 or BRCA2 genes and have previously received multiple lines of chemotherapy.

Side Effects Of Canrib 150mg Tablet

Like any medication, CANRIB 150mg (Olaparib) can cause side effects. Common side effects associated with CANRIB 150mg (Olaparib) 150mg include:

• Fatigue
• Anemia (low red blood cell count)
• Decreased appetite
• Respiratory tract infections

It is important to note that not all individuals will experience these side effects, and the severity may vary from person to person. If you are prescribed CANRIB 150mg (Olaparib), your healthcare provider will closely monitor you and provide guidance on managing any side effects that may arise.

It is crucial to consult with a healthcare professional for accurate and up-to-date information regarding the uses, dosage, and potential side effects of CANRIB 150mg (Olaparib) 150mg, as individual circumstances may vary.

Mechanism Of Action Of Canrib 150mg Tablet

The mechanism of action of CANRIB 150mg (Olaparib) involves inhibiting the activity of PARP enzymes. PARP enzymes play a role in repairing damaged DNA in cells. By inhibiting PARP, CANRIB 150mg (Olaparib) prevents the repair of damaged DNA in cancer cells, leading to their death. This mechanism is particularly effective in cancers that have deficiencies in DNA repair, such as those with mutations in the BRCA genes.